Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05244122 · ClinicalTrials.gov registry record · NA
PROJECT 2 EXAMPLE: Feedback X Prevalence Using Dermatology Stimuli
A NA study, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 1,121
- Enrollment target
NCT05244122 is a NA study that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 1,121 participants.
The verdict
NCT05244122, a NA study, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,121 participants
- Enrollment target
Study Summary
Imagine that a dermatologist spends the morning seeing patients who have been referred for suspicion of skin cancer. Many of them do, in fact, have skin lesions that require treatment. For this set of patients, disease 'prevalence' would be high. Suppose that the next task is to spend the afternoon giving annual screening exams to members of the general population. Here disease prevalence will be low. Would the morning's work influence decisions about patients in the afternoon? It is known from other contexts that recent history can influence current decisions and that target prevalence has an impact on decisions. In this study, decisions were decisions about skin lesions from individuals with varying degrees of expertise, using an online, medical imaging labelling app (DiagnosUs). This allowed examination of the effects of feedback history and prevalence in a single study. Blocks of trials could be of low or high prevalence, with or without feedback. Over 300,000 individual judgements were collected. (taken from Wolfe, J. M. (2022). How one block of trials influences the next: Persistent effects of disease prevalence and feedback on decisions about images of skin lesions in a large online study. . Cognitive Research: Principles and Implications (CRPI), 7, 10. doi: https://doi.org/10.1186/s41235-022-00362-0
Interventions
- BEHAVIORAL Feedback
- BEHAVIORAL Prevalence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,121 participants |
| Start Date | 2021-06-22 |
| Est. Completion | 2021-06-27 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05244122
The ClinicalTrials.gov registry entry for NCT05244122 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,121 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Feedback is the first listed.
NCT05244122 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05244122 about?
NCT05244122 is a clinical study titled "PROJECT 2 EXAMPLE: Feedback X Prevalence Using Dermatology Stimuli". Imagine that a dermatologist spends the morning seeing patients who have been referred for suspicion of skin cancer. Many of them do, in fact, have skin lesions that require treatment. For this set of patients, disease 'prevalence' would be high. Suppose that the next task is to spend the afternoon ...
What is the current status of trial NCT05244122?
This trial is currently completed. It is a NA study. The enrollment target is 1,121 participants. The study started on 2021-06-22. Estimated completion is 2021-06-27.
What interventions are being tested in trial NCT05244122?
The interventions under investigation include: Feedback (BEHAVIORAL), Prevalence (BEHAVIORAL).
Who is sponsoring clinical trial NCT05244122?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.